Bioxyne Limited

Q: What was Bioxyne Limited’s price range in the past 12 months?

Bioxyne Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.

Q: What is Bioxyne Limited’s market cap?

Bioxyne Limited’s market cap is AU$91.22M.

Q: When is Bioxyne Limited’s upcoming earnings report date?

Bioxyne Limited’s upcoming earnings report date is Feb 19, 2026 which is in 111 days.

Q: How were Bioxyne Limited’s earnings last quarter?

Bioxyne Limited released its earnings results on Aug 29, 2025. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.001.

Q: Is Bioxyne Limited overvalued?

According to Wall Street analysts Bioxyne Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Bioxyne Limited pay dividends?

Bioxyne Limited does not currently pay dividends.

Q: What is Bioxyne Limited’s EPS estimate?

Bioxyne Limited’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Bioxyne Limited have?

Bioxyne Limited has 2,171,828,600 shares outstanding.

Q: What happened to Bioxyne Limited’s price movement after its last earnings report?

Bioxyne Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -16.667%.

Q: Which hedge fund is a major shareholder of Bioxyne Limited?

Currently, no hedge funds are holding shares in AU:BXN

Compare

10 Followers

BXN Stock Chart & Stats

AU$0.04

<AU$0.01(4.17%)

At close: Jan 09 4:00 PM EST

AU$0.04

<AU$0.01(4.17%)

Day’s Range― - ―

52-Week RangeAU$0.01 - AU$0.06

Previous CloseN/A

Volume631.90K

Average Volume (3M)4.35M

Market Cap

AU$91.22M

Enterprise ValueAU$86.43M

Total Cash (Recent Filing)AU$7.67M

Total Debt (Recent Filing)AU$1.53M

Price to Earnings (P/E)17.5

Beta1.16

Next Earnings

Feb 19, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding2,171,828,600

10 Day Avg. Volume2,483,521

30 Day Avg. Volume4,348,514

Financial Highlights & Ratios

PEG Ratio-0.13

Price to Book (P/B)7.54

Price to Sales (P/S)2.90

P/FCF Ratio22.82

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusModerate Buy

Number of Analyst Covering0

Bioxyne Limited News

Bioxyne Limited Reports Strong FY25 Q1 Results and International Expansion

Bioxyne Limited ( ($AU:BXN) ) has shared an update. Bioxyne Limited has released its first quarter results for...

1d ago

BXN

Bioxyne Limited Achieves Record Revenue and Expands European Market Presence

Bioxyne Limited ( ($AU:BXN) ) just unveiled an announcement. Bioxyne Limited reported a record quarterly revenue of $14.1...

2d ago

BXN

Bioxyne Limited Announces Annual General Meeting for November 2025

Bioxyne Limited ( ($AU:BXN) ) just unveiled an announcement. Bioxyne Limited has announced its upcoming Annual General Meeting...

4d ago

BXN

Bioxyne Limited Announces 2025 Annual General Meeting

Bioxyne Limited ( ($AU:BXN) ) has shared an announcement. Bioxyne Limited has announced its Annual General Meeting (AGM)...

4d ago

BXN

Bioxyne Limited Announces Director’s Interest Change

An announcement from Bioxyne Limited ( ($AU:BXN) ) is now available. Bioxyne Limited has announced a change in...

4d ago

BXN

Bioxyne Limited Announces Quotation of New Securities

The latest update is out from Bioxyne Limited ( ($AU:BXN) ). Bioxyne Limited has announced the quotation of...

4d ago

BXN

Bioxyne Limited Expands European Presence with Frankfurt Stock Exchange Listing

The latest announcement is out from Bioxyne Limited ( ($AU:BXN) ). Bioxyne Limited has announced its dual listing...

19d ago

BXN

Bioxyne Positioned for Growth Amid U.S. Cannabis Rescheduling Prospects

Bioxyne Limited ( ($AU:BXN) ) has issued an update. Recent developments in U.S. cannabis classification, specifically the potential...

1M ago

BXN

Bioxyne Limited Updates Corporate Governance Statement

Bioxyne Limited ( ($AU:BXN) ) has provided an update. Bioxyne Limited has updated its corporate governance statement, which...

1M ago

BXN

Bioxyne Limited Secures German Import Permits for Medical Cannabis

Bioxyne Limited ( ($AU:BXN) ) has issued an update. Bioxyne Limited has received import authorizations from the German...

2M ago

BXN

BXN FAQ

What was Bioxyne Limited’s price range in the past 12 months?

Bioxyne Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.

What is Bioxyne Limited’s market cap?

Bioxyne Limited’s market cap is AU$91.22M.

When is Bioxyne Limited’s upcoming earnings report date?

Bioxyne Limited’s upcoming earnings report date is Feb 19, 2026 which is in 111 days.

How were Bioxyne Limited’s earnings last quarter?

Bioxyne Limited released its earnings results on Aug 29, 2025. The company reported AU$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.001.

Is Bioxyne Limited overvalued?

According to Wall Street analysts Bioxyne Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Bioxyne Limited pay dividends?

Bioxyne Limited does not currently pay dividends.

What is Bioxyne Limited’s EPS estimate?

Bioxyne Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Bioxyne Limited have?

Bioxyne Limited has 2,171,828,600 shares outstanding.

What happened to Bioxyne Limited’s price movement after its last earnings report?

Bioxyne Limited reported an EPS of AU$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -16.667%.

Which hedge fund is a major shareholder of Bioxyne Limited?

Currently, no hedge funds are holding shares in AU:BXN

Bioxyne Limited Stock Smart Score

Neutral

Fundamentals

Return on Equity

61.21%

Trailing 12-Months

Asset Growth

192.29%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Bioxyne Limited

Bioxyne Limited (BXN) is an Australian biotechnology company focused on developing and commercializing innovative health products, particularly in the areas of gut health, immune health, and overall wellness. The company specializes in the research and development of probiotics and prebiotics, with a strong emphasis on harnessing the benefits of naturally occurring microorganisms to enhance human health. Bioxyne's core products include its proprietary probiotic formulations and dietary supplements, aimed at improving digestive health and boosting the immune system.